Studies have shown that the function of inhibitory networks is disturbed in Fragile X. This abnormality is not well understood but appears to be secondary to abnormalities in metabotropic glutamate and endocannabinoid systems. With a $90,000 grant from FRAXA, Dr. Molly Huntsman’s team examined how these networks interact and how inhibitory deficits can best be remedied.
Read moreCea-Del Rio, Christian
Christian Cea-Del Rio, PhD, Assistant Professor at the University of Santiago, Chile, researches neurodevelopmental disorders. In 2013, Dr. Cea-Del Rio received a FRAXA Research Foundation grant to study cellular-specific therapeutic targets in Fragile X syndrome.